We have worked with the pharmaceutical compliance community for the past 4 years. There has been progression over the years as compliance programmes mature and focus changes for compliance professionals.
Low public confidence in how pharma conducts relationships and lack of transparency has meant governments have implemented a raft of reforms that have impacted compliance. Over the past year, with the implementation of EFPIA guidelines, there has been more and more discussion in the conference room, and in research about the challenges faced. We tailor the programme year after year to address the most pressing and emerging topics of highest relevance to the industry at that time.
The 4th annual Pharma Compliance Europe will unite senior compliance executives to share their experiences and explore these challenges. This is your opportunity to engage and benchmark your compliance programme and hear the latest operational best practices, transparency and disclosure review and due diligence and monitoring considerations. 2016 promises to be the biggest ever. Join us to learn how to future proof your compliance programme.